Enter assignee name

Forward Citations = 7

Loading Chart...

6 inventors (with patents filed for the assignee):

Timor Baasov (6 out of 22 patents)

Shmuel Tuvia (3 out of 3 patents)

Michael Mizhiritskii (1 out of 10 patents)

4. Mani Bushan Kotala (1 out of 1 patent)

5. Ravinder Palidi (1 out of 1 patent)

6. Dori Pelled (1 out of 1 patent)

7 patents: Sort by Forward Citations

1. 11786539 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2023-10-17),

2. 11613551 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2023-03-28),

3. 11306115 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2022-04-19),

4. 11136345 - Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof (2021-10-05),

5. 10899785 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2021-01-26),

6. 10786520 - Aminoglycoside derivatives and uses thereof in treating genetic disorders (2020-09-29),

7. 10576095 - Use of aminoglycoside analogs in the treatment of Rett syndrome (2020-03-03),

Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapeutics for the treatment of rare and ultra-rare genetic diseases. The company's lead product candidate, ELX-02, is being studied for the treatment of cystic fibrosis and other genetic disorders. Eloxx Pharmaceuticals is committed to improving the lives of patients with unmet medical needs through the advancement of innovative therapies.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

7 Patents

#38 in Rehovot

#864 in Israel

Rehovot, Israel

Eloxx Pharmaceuticals Ltd.